GlassScriptPhysician profile
Andrew D Vanosdol
NPI 1710203401
$13,529.27
in general payments reported to CMS, 2019-2025
19 companies · $17.23 in 2025
The $17.23 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,296 · 2020: $367 · 2021: $342 · 2022: $1,714 · 2023: $3,643 · 2024: $149 · 2025: $17.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,647 · Food and Beverage: $1,147 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,646.94 |
| Food and Beverage | $1,146.66 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $5,353.42 | 2019-2023 | Linx Reflux Management System |
| Intuitive Surgical, INC. | $3,603.00 | 2020-2023 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $2,200.80 | 2019-2022 | |
| Stryker Corporation | $1,533.23 | 2019-2022 | |
| Endogastric Solutions, INC | $155.97 | 2019-2022 | |
| Steris Corporation | $107.50 | 2022 | |
| Boston Scientific Corporation | $73.42 | 2023 | |
| Davol INC. | $73.14 | 2024 | Phasix Mesh |
| Medtronic Vascular, INC. | $53.07 | 2019 | |
| Sioux Surgical INC | $52.14 | 2024 | |
| Covidien LP | $51.33 | 2019 | |
| Smith+Nephew, INC. | $51.14 | 2019 | |
| Olympus America INC. | $46.16 | 2020 | |
| Medtronic, INC. | $45.33 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $44.05 | 2023 | Iovera, Exparel, Zilretta |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Erbe USA INC | $24.20 | 2021 | |
| Tela Bio, INC. | $24.01 | 2024 | Ovitex 2s |
| Apollo Endosurgery US INC | $20.13 | 2022 | |
| Heron Therapeutics, INC. | $17.23 | 2025 | Aponvie |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Vanosdol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.